Cited 0 times in
Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, DJ | - |
dc.contributor.author | Moon, SH | - |
dc.contributor.author | Kim, H | - |
dc.contributor.author | Kwon, UH | - |
dc.contributor.author | Park, MS | - |
dc.contributor.author | Han, KJ | - |
dc.contributor.author | Hahn, SB | - |
dc.contributor.author | Lee, HM | - |
dc.date.accessioned | 2011-07-22T02:07:03Z | - |
dc.date.available | 2011-07-22T02:07:03Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | 0362-2436 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/3525 | - |
dc.description.abstract | STUDY DESIGN: In vitro experiment using bone morphogenetic protein-2 (BMP-2) and human intervertebral disc (IVD) cells.
OBJECTIVES: To demonstrate the effect of BMP-2 on mRNAs expression (collagen type I, collagen type II, aggrecan, and osteocalcin), proteoglycan synthesis, expression of alkaline phosphatase, bone nodule formation in human IVD cells. SUMMARY OF BACKGROUND DATA: BMP-2 was widely known as a powerful agent for osteoinduction and a crucial growth factor for early chondrogenesis and maintenance of cartilaginous phenotype. BMP-2 proved to be effective in stimulating proteoglycan synthesis in articular chondrocytes and IVD cells. Nevertheless, the effect of BMP-2 on IVD cells, whether chondrogenic or osteogenic, was not thoroughly elucidated in transcriptional level and histochemical stains. MATERIALS AND METHODS: Human IVDs were harvested and enzymatically digested. Then IVD cells were cultured three-dimensionally in alginate beads. Osteoblasts were cultured from cancellous bone of ilium for histochemical stains. Recombinant human BMP-2 (rhBMP-2) was produced by Chinese hamster ovary cells after transduction of BMP-2 cDNA, then concentrated and purified. Then IVD cell cultures were exposed to various concentrations of rhBMP-2. Reverse transcription-polymerase chain reaction for mRNA expression of aggrecan, collagen type I, collagen type II, and osteocalcin was performed. Newly synthesized proteoglycan was measured by 35S-sulfate incorporation on Sephadex G-25 M in PD 10 columns. As a histochemical examination, alkaline phosphatase and Alizarin red-S stains were used to detect osteogenic marker and bone nodule formation, respectively. RESULTS: In the rhBMP-2 treated cultures, there was increased newly synthesized proteoglycan (67% in 300 ng/mL and 200% in 1,500 ng/mL of rhBMP-2) and up-regulated expression of aggrecan, collagen type I, and collagen type II mRNA over untreated control. However, rhBMP-2 did not up-regulate expression of osteocalcin mRNA in the given dose and culture period. IVD cell cultures with rhBMP-2 showed no evidence of bone formation in histochemical stains, i.e., alkaline phosphatase and Alizarin red-S, while osteoblast culture exhibited strong positive stains. CONCLUSIONS: The rhBMP-2 clearly up-regulated mRNA expression of chondrogenic components and also stimulated proteoglycan synthesis without expression of osteogenic phenotype. Taken together, this study raise the possibility of rhBMP-2 can be anabolic agent for regenerating matrix of intervertebral disc. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aggrecans | - |
dc.subject.MESH | Alkaline Phosphatase | - |
dc.subject.MESH | Anthraquinones | - |
dc.subject.MESH | Bone Morphogenetic Protein 2 | - |
dc.subject.MESH | Bone Morphogenetic Proteins | - |
dc.subject.MESH | Cells, Cultured | - |
dc.subject.MESH | Chondrocytes | - |
dc.subject.MESH | Collagen Type I | - |
dc.subject.MESH | Collagen Type II | - |
dc.subject.MESH | Coloring Agents | - |
dc.subject.MESH | Extracellular Matrix Proteins | - |
dc.subject.MESH | Gene Expression | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Intervertebral Disk | - |
dc.subject.MESH | Lectins, C-Type | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Osteoblasts | - |
dc.subject.MESH | Osteocalcin | - |
dc.subject.MESH | Phenotype | - |
dc.subject.MESH | Proteoglycans | - |
dc.subject.MESH | RNA, Messenger | - |
dc.subject.MESH | Recombinant Proteins | - |
dc.subject.MESH | Transforming Growth Factor beta | - |
dc.title | Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. | - |
dc.type | Article | - |
dc.identifier.pmid | 14673369 | - |
dc.identifier.url | http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=28&issue=24&spage=2679 | - |
dc.contributor.affiliatedAuthor | 한, 경진 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1097/01.BRS.0000101445.46487.16 | - |
dc.citation.title | Spine | - |
dc.citation.volume | 28 | - |
dc.citation.number | 24 | - |
dc.citation.date | 2003 | - |
dc.citation.startPage | 2679 | - |
dc.citation.endPage | 2684 | - |
dc.identifier.bibliographicCitation | Spine, 28(24). : 2679-2684, 2003 | - |
dc.identifier.eissn | 1528-1159 | - |
dc.relation.journalid | J003622436 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.